Allogene Therapeutics (ALLO) Long-Term Investments (2018 - 2026)
Allogene Therapeutics (ALLO) recorded Long-Term Investments of $90.99 million in Q2 2026, up 208.3% from $29.51 million a year earlier.
Powered by 
Analysis
Allogene Therapeutics (ALLO) Long-Term Investments (2018 - 2026) Analysis & Trends
At the end of FY2025, Allogene Therapeutics reported Long-Term Investments of $8.04 million, down 90.0% from FY2024.
- Annual Long-Term Investments has a five-year compound annual growth rate of -47.6% (FY2020 to FY2025).
- Across earlier years, Long-Term Investments came in at $80.67 million in FY2024, $3.65 million in FY2023 (-93.8%), $59.15 million in FY2022 (-83.2%) and $352.18 million in FY2021 (+72.5%).
- The Q2 2026 figure is the highest quarterly Long-Term Investments since Q3 2024.
- On a year-over-year basis, Long-Term Investments rose in three of the last five quarters, with growth averaging 127.1%.
- Peak year-over-year performance for Long-Term Investments in the last five years was growth of 347.4% in Q1 2025, against a decline of 97.8% in Q2 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 266.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.22 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 69.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.62 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.56 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.79 Bn |
| 10 | Allogene Therapeutics | 552.55 Mn | 552.55 Mn | - | 90.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 90.99 Mn |
| Dec 31, 2025 | 8.04 Mn |
| Sep 30, 2025 | 24.94 Mn |
| Jun 30, 2025 | 29.51 Mn |
| Mar 31, 2025 | 55.51 Mn |
| Dec 31, 2024 | 80.67 Mn |
| Sep 30, 2024 | 111.82 Mn |
| Jun 30, 2024 | 1.13 Mn |
| Mar 31, 2024 | 12.41 Mn |
| Dec 31, 2023 | 3.65 Mn |
| Sep 30, 2023 | 32.17 Mn |
| Jun 30, 2023 | 52.59 Mn |
| Mar 31, 2023 | 42.79 Mn |
| Dec 31, 2022 | 59.15 Mn |
| Sep 30, 2022 | 85.11 Mn |
| Jun 30, 2022 | 195.64 Mn |
| Mar 31, 2022 | 284.09 Mn |
| Dec 31, 2021 | 352.18 Mn |
| Sep 30, 2021 | 378.22 Mn |
| Jun 30, 2021 | 325.52 Mn |
API Access
Allogene Therapeutics Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=ALLO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "ALLO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=ALLO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();